Event Co-Sponsor
This event will feature live presentations from executives of leading mental health companies. The agenda highlights companies representing research, drug development, patient care delivery, and patient support services.
Thursday, December 15th Agenda
9:30 AM ET
Orexo AB
OTCQX: ORXOY | Nasdaq STO: ORX
Nikolaj Sørensen, President & CEO
10:00 AM ET
Reunion Neuroscience Inc.
Nasdaq: REUN
Greg Mayes, President & CEO
10:30 AM ET
nDatalyze Corp.
OTCQB: NDATF | CSE: NDAT
James Durward, President & CEO
11:00 AM ET
Field Trip Health & Wellness Ltd
Pink: FTHWF | TSX-V: FTHW
Ronan Levy, Founder & CEO
11:30 AM ET
PsychoGenics
Daniela Brunner, Chief Innovation Officer
12:00 PM ET
Filament Health Corp
OTCQB: FLHLF | NEO:FH | FSE:7QS
Ben Lightburn, CEO & Co-Founder
12:30 PM ET
Numinus Wellness
OTCQX: NUMIF | TSX: NUMI
Payton Nyquvest, CEO & Founder
1:00 PM ET
Vistagen Therapeutics, Inc
Nasdaq: VTGN
Shawn Singh, CEO & Director
1:30 PM ET
PharmAla Biotech Holdings Inc.
CSE: MDMA
Nicholas Kadysh, CEO
2:00 PM ET
Tryp Therapeutics Inc.
OTCQB: TRYPF | CSE: TRYP
Jim Gilligan, Interim CEO, President and Chief Scientific Officer
{"@context": "https://schema.org","@type": "Event","name": "Life Science Investor Forum","startDate": "2022-12-15T11:00:00-05:00","eventAttendanceMode": "OnlineEventAttendanceMode","image": ["https://otcmarkets.gcs-web.com/static-files/437fc1c3-ca26-4d39-a781-a357d5847908","https://otcmarkets.gcs-web.com/static-files/3db571b2-b29d-4d02-876f-72d71238ae2f","https://otcmarkets.gcs-web.com/static-files/782beb53-55a6-4811-adff-7757e116f0f4"],"location":{"@type": "VirtualLocation","url": "https://www.virtualinvestorconferences.com/events/event-details/kcsa-mental-health-investor-conference"},"description": "Virtual Investor Conferences combine leading-edge online conferencing and investor communications capabilities with a comprehensive global investor audience network. This event will feature live presentations from executives of leading mental health companies. The agenda highlights companies representing research, drug development, patient care delivery, and patient support services."}